Alpine Immune Sciences Inc (ALPN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,552 | N/A | 524,901 | 247,055 | 142,047 |
| Marketable Securities | N/A | N/A | 393,837 | 424,196 | 359,323 |
| Receivables | N/A | N/A | 188,422 | 256,731 | 150,624 |
| Inventories | N/A | N/A | 213,869 | 208,894 | 162,213 |
| Other current assets | 0 | 0 | 88,110 | 65,525 | 83,615 |
| TOTAL | $1,803 | $N/A | $1,409,139 | $1,202,401 | $897,822 |
| Non-Current Assets | |||||
| PPE Net | 175 | N/A | 208,764 | 218,569 | 239,111 |
| Investments And Advances | 0 | 0 | 42,890 | 68,640 | 78,760 |
| Other Non-Current Assets | 2,156 | 0 | 275,830 | 342,770 | 343,270 |
| TOTAL | $2,332 | $N/A | $527,484 | $629,979 | $661,141 |
| Total Assets | $4,134 | $N/A | $1,936,635 | $1,832,397 | $1,558,978 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 671 | 0 | 51,190 | 82,000 | 72,650 |
| Accrued Expenses | 1,347 | N/A | 159,500 | 93,230 | 88,150 |
| Other current liabilities | N/A | N/A | 15,990 | 100,130 | 9,090 |
| TOTAL | $4,012 | $N/A | $232,231 | $291,011 | $171,494 |
| Non-Current Liabilities | |||||
| Long Term Debt | 13,350 | N/A | 103,189 | 105,592 | 114,147 |
| Other Non-Current Liabilities | 268 | 0 | 377,590 | 107,650 | 93,560 |
| TOTAL | $13,618 | $N/A | $603,859 | $213,242 | $207,707 |
| Total Liabilities | $17,629 | $N/A | $836,105 | $504,259 | $379,201 |
| Shareholders' Equity | |||||
| Common Shares | 0 | N/A | 1,293,810 | 1,206,880 | 1,179,220 |
| Retained earnings | -110,983 | N/A | -191,031 | 124,132 | 5,226 |
| Other shareholders' equity | 77,795 | 0 | -2,249 | -2,874 | -4,669 |
| TOTAL | $-13,495 | $N/A | $1,100,530 | $1,328,138 | $1,179,777 |
| Total Liabilities And Equity | $4,134 | $0 | $1,936,635 | $1,832,397 | $1,558,978 |